Robert Karr
Joho Capital
Robert Karr MINDRAY MEDICAL INTL LTD-ADR stake
total: 89
Joho Capital MR trades
- Total transactions:
- 4
- New positions:
- 1
- Sold out:
- 1
- Reduced:
- 2
- Held since:
- 2013 Q2 or earlier
- Held for:
- 3+ quarters
- Latest activity:
- 2014 Q1
According to 2026 Q1 report, Robert Karr doesn't hold any MINDRAY MEDICAL INTL LTD-ADR (MR) shares. Joho Capital has held MR since at least 2013 Q2 with about 2.25M shares in our earliest available record. Since at least 2013 Q2, Joho Capital has made 3 more transactions.
When did Robert Karr sell MINDRAY MEDICAL INTL LTD-ADR (MR)?
Robert Karr sold off the entire MINDRAY MEDICAL INTL LTD-ADR (MR) position in 2014 Q1.
Estimated cost basis*
- Weighted AVG buy price:
- $37.45
- Weighted AVG sell price:
- $36.62
Robert Karr's historical trades in MINDRAY MEDICAL INTL LTD-ADR
4 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2014 Q1
|
0.00%
|
$36.36
|
-100% (-656,715)
|
|||
|
2013 Q4
|
1.63%
|
$36.36
|
-67.40% (-1,357,817)
|
|||
|
2013 Q3
|
5.88%
|
$38.89
|
-10.38% (-233,349)
|
|||
|
2013 Q2
|
7.21%
|
$37.45
|
new or own*
|
|||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.